TY - JOUR
T1 - Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle
AU - Domínguez-López, Sergio
AU - Mahar, Ian
AU - Bambico, Francis Rodriguez
AU - Labonté, Benoit
AU - Ochoa-Sánchez, Rafael
AU - Leyton, Marco
AU - Gobbi, Gabriella
N1 - Funding Information:
This work was supported by grants from the Fonds de la Recherche en Santé du Québec (FRSQ, to GG and FRB), the Canadian Institutes of Health Research (CIHR, #PPP-81421 and #PP2-90159 to GG), the Canadian Foundation for Innovation (CFI, #23381 to GG), the Ministère du Développement Économique de l’ Innovation et de l’Exportation (MDEIE, #230301 to GG), the McGill University Health Center (MUHC, to GG and FRB), and McGill University (William Dawson Scholar Fund to ML). SDL was supported by a scholarship from the Mexican National Council for Science and Technology (CONACYT, Reg. 193202/302017), and partially supported by the Robert C Paterson McGill University Award.
PY - 2012/6
Y1 - 2012/6
N2 - Melatonin (MLT) and serotonin (5-HT) are two biosynthetically related compounds implicated in several common physiological functions and the etiology of mood disorders. How they interact, though, is not yet fully understood. In this study, single-unit extracellular recordings were used to monitor dorsal raphe nucleus (DR) 5-HT neuronal activity in anesthetized rats, under basal conditions (CTRL), in response to MLT administration, and after pinealectomy (PX) across the light-dark cycle. Under basal conditions, the number of spontaneously active 5-HT neurons and their firing rate were both significantly lower in the dark phase. In the light phase, administration of MLT at low doses (0.5-1mg/kg, i.v.) decreased 5-HT firing activity. This inhibitory effect of MLT was completely blocked by the MT1/MT2 receptor antagonist luzindole, but not by the selective MT2 receptor antagonist 4P-PDOT, the selective 5-HT1A receptor antagonist WAY100635, or by the α2 adrenoceptor antagonist idazoxan. In the opposite experiment, PX increased 5-HT firing activity in the dark phase, and this was reversed by MLT administration (1mg/kg, i.v.). Finally, in a forced swim test, MLT (1mg/kg, i.p.) increased immobility time and decreased swimming behavior. Together, these results suggest that nocturnal MLT secretion imposes tonic inhibitory control over a sub-population of DR 5-HT neurons. This MLT-induced decrease in 5-HT neurotransmission may represent a biological mechanism underlying mood disorders characterized by increased MLT secretion, such as seasonal affective disorder.
AB - Melatonin (MLT) and serotonin (5-HT) are two biosynthetically related compounds implicated in several common physiological functions and the etiology of mood disorders. How they interact, though, is not yet fully understood. In this study, single-unit extracellular recordings were used to monitor dorsal raphe nucleus (DR) 5-HT neuronal activity in anesthetized rats, under basal conditions (CTRL), in response to MLT administration, and after pinealectomy (PX) across the light-dark cycle. Under basal conditions, the number of spontaneously active 5-HT neurons and their firing rate were both significantly lower in the dark phase. In the light phase, administration of MLT at low doses (0.5-1mg/kg, i.v.) decreased 5-HT firing activity. This inhibitory effect of MLT was completely blocked by the MT1/MT2 receptor antagonist luzindole, but not by the selective MT2 receptor antagonist 4P-PDOT, the selective 5-HT1A receptor antagonist WAY100635, or by the α2 adrenoceptor antagonist idazoxan. In the opposite experiment, PX increased 5-HT firing activity in the dark phase, and this was reversed by MLT administration (1mg/kg, i.v.). Finally, in a forced swim test, MLT (1mg/kg, i.p.) increased immobility time and decreased swimming behavior. Together, these results suggest that nocturnal MLT secretion imposes tonic inhibitory control over a sub-population of DR 5-HT neurons. This MLT-induced decrease in 5-HT neurotransmission may represent a biological mechanism underlying mood disorders characterized by increased MLT secretion, such as seasonal affective disorder.
KW - Circadian
KW - electrophysiology
KW - light-dark cycle
KW - melatonin
KW - pineal gland
KW - seasonal depression
KW - serotonin
UR - https://www.scopus.com/pages/publications/84862147652
U2 - 10.1177/0269881111408460
DO - 10.1177/0269881111408460
M3 - Article
C2 - 21730015
AN - SCOPUS:84862147652
SN - 0269-8811
VL - 26
SP - 830
EP - 844
JO - Journal of Psychopharmacology
JF - Journal of Psychopharmacology
IS - 6
ER -